Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) CEO William Sibold sold 6,362 shares of the stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $535.59, for a total transaction of $3,407,423.58. Following the completion of the transaction, the chief executive officer owned 202,967 shares […]

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) CEO William Sibold sold 5,221 shares of the stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $542.39, for a total transaction of $2,831,818.19. Following the transaction, the chief executive officer owned 197,746 shares in the company, valued at […]